Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
March 26, 2024
When we launched Pandemic Proof, many countries were still in the throes of the health and economic shocks of COVID-19. Lessons learned from the pandemic were still fresh. And the visibility and urgency of the pandemic catalyzed some important policy action, including the establishment of innovative...
Blog Post
February 26, 2024
As most of the developing world struggles to increase, let alone maintain current levels of domestic health expenditure, getting more health for the money has never been more important. Building robust health technology assessment (HTA) systems to inform governments on which health technologies and ...
Blog Post
January 10, 2024
This blog outlines key considerations regarding how the AEF raises and spends funds, underscoring the significance of a robust design and effective implementation at a time when the AEF’s proposed governance and operational mechanisms are being deliberated on and presented to the AU policy organs fo...
Oct
11
2023
VIRTUAL
9:30—10:30 AM ET / 2:30-3:30 PM BST
September 28, 2023
Achieving universal health coverage (UHC) requires strong primary health care systems—which, in turn, requires adequate financing. The United Nations General Assembly High-Level Meeting on UHC earlier this fall reiterated the importance of primary care and UHC as global priorities. However, funds to...
POLICY PAPERS
June 20, 2023
This policy paper examines the state of knowledge on investing in the “best buys” of surveillance for pandemic preparedness. We conduct a rapid literature review to assess the state of knowledge on the costs and benefits of investing in four selected types of surveillance for respiratory infections,...
Blog Post
May 02, 2023
The investment case for bolstering global systems for pandemic preparedness and response is clear. Yet, COVID-19 exposed gaping holes in our collective ability to respond to pandemic threats. And even after more than 6.9 million deaths from COVID-19 and trillions in economic losses, financing and po...
Blog Post
April 11, 2023
In this blog, we make the case that WHO should shift away from disease siloes and reorganize to streamline the cross-cutting functions that it delivers to member countries. The WHO has an opportunity to streamline its functions along the continuum of science practice—from registering clinical trials...
Blog Post
February 23, 2023
How can we ensure that medical countermeasures—such as diagnostics and vaccines—are ready to go at local, national, and global levels when the next pandemic emerges? Amanda Glassman speaks with Dr. Amadou Alpha Sall of Institut Pasteur of Dakar and Dr. Rachel Glennerster of the University of Chicago...
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...